🕵️ Strata Critical Medical, Inc. ($SRTA)
SEC insider & ownership activity, last 12 months · CIK 1779128 · every row links its SEC filing
Over the last 12 months insiders sold $927K against $98K of open-market buying. Cohen Amir sold $410K through a 10b5-1 trading plan in 4 lots (May–Jun). BlackRock, Inc. trimmed 5.2% → 5.1%. No red-flag 8-Ks in the window.
🚨 1 signal active —
planned-vs-executed verdicts, pre-event flags, and cluster context live in the
API and the
alerts bot.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
2 buyers, $98K (2 lots) · 5 sellers, $927K (10 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Cohen Amir | 0 | – | 4 | $410K | Jun 8, 2026 |
| William A. Heyburn | 1 | $76K | 1 | $186K | Jun 8, 2026 |
| Melissa M. Tomkiel | 0 | – | 1 | $175K | Jun 8, 2026 |
| Reginald Lamonte Love | 0 | – | 3 | $125K | Aug 10, 2026 |
| Scott M. Wunsch | 0 | – | 1 | $33K | Jun 8, 2026 |
| Lauck Andrew | 1 | $22K | 0 | – | Dec 5, 2025 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Steele ExpCo Holdings, LLC | 9.0% | Class A | 13G | Aug 20, 2026 | filing ↗ |
| KSL Capital Partners V GP, LLC | 9.0% | Class A | 13G | Aug 20, 2026 | filing ↗ |
| Eric Charles Resnick | 9.0% | Class A | 13G | Aug 20, 2026 | filing ↗ |
| Third Point LLC | 5.8% | 13G | Nov 14, 2025 | filing ↗ | |
| Daniel S. Loeb | 5.8% | 13G | Nov 14, 2025 | filing ↗ | |
| BlackRock, Inc. | 5.1% | 13G | Jan 21, 2026 | filing ↗ | |
| Northern Right Capital Management, L.P. | 5.1% | 13G | Jun 17, 2026 | filing ↗ | |
| BC Advisors LLC | 5.1% | 13G | Jun 17, 2026 | filing ↗ | |
| Matthew A. Drapkin | 5.1% | 13G | Jun 17, 2026 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Amir Cohen | $363K | May 11, 2026 | filing ↗ |
| Reginald Lamonte Love | $48K | Nov 20, 2025 | filing ↗ |
| Reginald Lamonte Love | $47K | Nov 19, 2025 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Earnings (2.02) | Aug 4, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 4, 2026 | filing ↗ |
| Shareholder vote (5.07) | May 28, 2026 | filing ↗ |
| Earnings (2.02) | May 6, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 6, 2026 | filing ↗ |
| Earnings (2.02) | Mar 3, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 3, 2026 | filing ↗ |
| Material agreement (1.01) | Jan 30, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jan 30, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 30, 2026 | filing ↗ |
| Officer/director changes (5.02) | Dec 2, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Dec 2, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 2, 2025 | filing ↗ |
| Earnings (2.02) | Nov 10, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 10, 2025 | filing ↗ |
| Acquisition or disposition (2.01) | Sep 16, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Sep 16, 2025 | filing ↗ |